In 2024, the average number of children born per 1,000 people in China ranged at 6.77. The birth rate has dropped considerably since 2016, and the number of births fell below the number of deaths in 2022 for the first time in decades, leading to a negative population growth rate. Recent development of the birth rate Similar to most East-Asian countries and territories, demographics in China today are characterized by a very low fertility rate. As low fertility in the long-term limits economic growth and leads to heavy strains on the pension and health systems, the Chinese government decided to support childbirth by gradually relaxing strict birth control measures, that had been in place for three decades. However, the effect of this policy change was considerably smaller than expected. The birth rate increased from 11.9 births per 1,000 inhabitants in 2010 to 14.57 births in 2012 and remained on a higher level for a couple of years, but then dropped again to a new low in 2018. This illustrates that other factors constrain the number of births today. These factors are most probably similar to those experienced in other developed countries as well: women preferring career opportunities over maternity, high costs for bringing up children, and changed social norms, to name only the most important ones. Future demographic prospects Between 2020 and 2023, the birth rate in China dropped to formerly unknown lows, most probably influenced by the coronavirus pandemic. As all COVID-19 restrictions were lifted by the end of 2022, births figures showed a catch-up effect in 2024. However, the scope of the rebound might be limited. A population breakdown by five-year age groups indicates that the drop in the number of births is also related to a shrinking number of people with child-bearing age. The age groups between 15 and 29 years today are considerably smaller than those between 30 and 44, leaving less space for the birth rate to increase. This effect is exacerbated by a considerable gender gap within younger age groups in China, with the number of females being much lower than that of males.

In 2023, the birth rate across different regions in China varied from around 13.7 births per 1,000 inhabitants (per mille) in Tibet to 2.9 per mille in Heilongjiang province. The average national birth rate ranged at 6.4 per mille that year. High disparity of birth rates across China Regional birth rates in China reach their highest values in western and southwestern provinces and autonomous regions. In this part of the country, the economy is less developed than in the coastal provinces and traditional values are more prevalent. At the same time, many people from minority communities live in these areas, who were less affected by strict birth control measures in the past and traditionally have more children. In contrast, the lowest birth rates in recent years were registered in the northwestern provinces Jilin, Liaoning, and Heilongjiang, which is the rust belt of China. This region offers few economic opportunities, and many young people leave for a better life in the eastern provinces. They often leave old people behind, which is one reason why these provinces also have some of the highest mortality rates in China. Future developments As most Chinese regions with a higher fertility rate have only few inhabitants, they cannot compensate for the increasing number of provinces with a declining populace. In the future, only economically successful cites will be able to escape this trend, while many provinces and rural areas will slowly lose a significant share of their population.

In 2024, the mortality rate in China ranged at approximately 7.76 deaths per 1,000 inhabitants. The mortality rate in China displayed an uneven development over the last two decades. This is mainly related to the very uneven sizes of Chinese age groups, improvements in health care, and the occurrence of epidemics. However, an overall growing trend is undisputable and related to China's aging population. As the share of the population aged 60 and above will be growing significantly over the upcoming two decades, the mortality rate will further increase in the years ahead. Population in China China was the second most populous country in the world in 2024. However, due to several mechanisms put into place by the Chinese government as well as changing circumstances in the working and social environment of the Chinese people, population growth has subsided over the past decades and finally turned negative in 2022. The major factor for this development was a set of policies introduced by the Chinese government in 1979, including the so-called one-child policy, which was intended to improve people’s living standards by limiting the population growth. However, with the decreasing birth rate and slower population growth, China nowadays is facing the problems of a rapidly aging population. Birth control in China According to the one-child policy, a married couple was only allowed to have one child. Only under certain circumstances were parents allowed to have a second child. As the performance of family control had long been related to the assessment of local government’s achievements, violations of the rule were severely punished. The birth control in China led to a decreasing birth rate and a more skewed gender ratio of new births due to a widely preference for male children in the Chinese society. Nowadays, since China’s population is aging rapidly, the one-child policy has been re-considered as an obstacle for the country’s further economic development. Since 2014, the one-child policy has been gradually relaxed and fully eliminated at the end of 2015. In May 2021, a new three-child policy has been introduced. However, many young Chinese people today are not willing to have more children due to high costs of raising a child, especially in urban areas.

In 2024, there were around 719 million male inhabitants and 689 million female inhabitants living in China, amounting to around 1.41 billion people in total. China's total population decreased for the first time in decades in 2022, and population decline is expected to accelerate in the upcoming years. Birth control in China From the beginning of the 1970s on, having many children was no longer encouraged in mainland China. The one-child policy was then introduced in 1979 to control the total size of the Chinese population. According to the one-child policy, a married couple was only allowed to have one child. With the time, modifications were added to the policy, for example parents living in rural areas were allowed to have a second child if the first was a daughter, and most ethnic minorities were excepted from the policy. Population ageing The birth control led to a decreasing birth rate in China and a more skewed gender ratio of new births due to boy preference. Since the negative economic and social effects of an aging population were more and more felt in China, the one-child policy was considered an obstacle for the country’s further economic development. Since 2014, the one-child policy has been gradually relaxed and fully eliminated at the end of 2015. However, many young Chinese people are not willing to have more children due to high costs of raising a child, especially in urban areas.

The statistic shows the 20 countries with the lowest fertility rates in 2024. All figures are estimates. In 2024, the fertility rate in Taiwan was estimated to be at 1.11 children per woman, making it the lowest fertility rate worldwide. Fertility rate The fertility rate is the average number of children born per woman of child-bearing age in a country. Usually, a woman aged between 15 and 45 is considered to be in her child-bearing years. The fertility rate of a country provides an insight into its economic state, as well as the level of health and education of its population. Developing countries usually have a higher fertility rate due to lack of access to birth control and contraception, and to women usually foregoing a higher education, or even any education at all, in favor of taking care of housework. Many families in poorer countries also need their children to help provide for the family by starting to work early and/or as caretakers for their parents in old age. In developed countries, fertility rates and birth rates are usually much lower, as birth control is easier to obtain and women often choose a career before becoming a mother. Additionally, if the number of women of child-bearing age declines, so does the fertility rate of a country. As can be seen above, countries like Hong Kong are a good example for women leaving the patriarchal structures and focusing on their own career instead of becoming a mother at a young age, causing a decline of the country’s fertility rate. A look at the fertility rate per woman worldwide by income group also shows that women with a low income tend to have more children than those with a high income. The United States are neither among the countries with the lowest, nor among those with the highest fertility rate, by the way. At 2.08 children per woman, the fertility rate in the US has been continuously slightly below the global average of about 2.4 children per woman over the last decade.

The China contraceptive devices market, valued at $711.73 million in 2025, is projected to experience robust growth, driven by increasing awareness of family planning, rising urbanization, and government initiatives promoting reproductive health. A Compound Annual Growth Rate (CAGR) of 6.10% from 2025 to 2033 indicates a significant expansion of this market over the forecast period. Key market segments include condoms, which currently hold a substantial market share due to affordability and accessibility, followed by intrauterine devices (IUDs) and diaphragms. The market is further segmented by end-user, with male and female contraceptive device usage reflecting evolving societal norms and preferences. Major players like Guangzhou ICLEAR Healthcare Limited, Bayer Healthcare, and Reckitt Benckiser are actively shaping market dynamics through product innovation, strategic partnerships, and expanding distribution networks. Growth is anticipated to be fuelled by increasing female economic empowerment, leading to greater control over reproductive choices. Conversely, challenges include lingering social stigmas around contraception in certain regions, as well as potential regulatory hurdles and variations in contraceptive access across different socioeconomic strata. The increasing demand for a wider range of contraceptive options, including more convenient and discreet methods, is also expected to drive innovation and investment within the market. The forecast for the China contraceptive devices market suggests a continued upward trajectory, driven primarily by demographic changes, evolving societal attitudes, and government support for family planning programs. The consistent adoption of effective contraceptive measures is likely to contribute significantly to the market's growth. While competitive pressures exist among established players and new entrants, the overall market potential remains substantial given China's vast population and evolving healthcare landscape. Furthermore, opportunities exist for companies focused on developing and marketing innovative, accessible, and user-friendly products catering to specific demographics and preferences. This includes exploring digital channels to improve awareness and access to contraceptive information and services. Recent developments include: In February 2022, the Government of China began an online propaganda campaign focused on how to respect the social value of childbirth and advocate age-appropriate marriage and childbearing, as well as optimal child-bearing and raising. This campaign is expected to increase awareness about contraceptive devices in the country, which may boost the market's growth., In June 2021, DKT WomanCare and Shanghai Dahua Pharmaceutical announced the price reduction of their Levoplant contraceptive implant to USD 6.70, thus increasing the affordability of these devices., In April 2021, Daxiang, a Beijing-based condom company, announced that they had sued Durex for plagiarizing their copyright-protected "butter box" product design, which was registered as a patent by the brand.. Key drivers for this market are: Rising Cases of Sexually Transmitted Diseases, Government Initiatives Regarding the Usage of Contraceptive Devices. Potential restraints include: Rising Cases of Sexually Transmitted Diseases, Government Initiatives Regarding the Usage of Contraceptive Devices. Notable trends are: Intrauterine Devices are Expected to Hold a Significant Share in the Market During the Forecast Period.

According to latest figures, the Chinese population decreased by 1.39 million to around 1.408 billion people in 2024. After decades of rapid growth, China arrived at the turning point of its demographic development in 2022, which was earlier than expected. The annual population decrease is estimated to remain at moderate levels until around 2030 but to accelerate thereafter. Population development in China China had for a long time been the country with the largest population worldwide, but according to UN estimates, it has been overtaken by India in 2023. As the population in India is still growing, the country is very likely to remain being home of the largest population on earth in the near future. Due to several mechanisms put into place by the Chinese government as well as changing circumstances in the working and social environment of the Chinese people, population growth has subsided over the past decades, displaying an annual population growth rate of -0.1 percent in 2024. Nevertheless, compared to the world population in total, China held a share of about 17 percent of the overall global population in 2024. China's aging population In terms of demographic developments, the birth control efforts of the Chinese government had considerable effects on the demographic pyramid in China. Upon closer examination of the age distribution, a clear trend of an aging population becomes visible. In order to curb the negative effects of an aging population, the Chinese government abolished the one-child policy in 2015, which had been in effect since 1979, and introduced a three-child policy in May 2021. However, many Chinese parents nowadays are reluctant to have a second or third child, as is the case in most of the developed countries in the world. The number of births in China varied in the years following the abolishment of the one-child policy, but did not increase considerably. Among the reasons most prominent for parents not having more children are the rising living costs and costs for child care, growing work pressure, a growing trend towards self-realization and individualism, and changing social behaviors.

Note: BMI = body mass index; FSH = follicle-stimulating hormone; LH = luteinizing hormone.a The independent samples t-test was conducted to compare the syphilis and control groups, and the values are presented as the mean ± standard deviation.b A significant difference was detected between the syphilis and control groups using the independent samples t-test (P

The graph shows the population growth in China from 2000 to 2024. In 2024, the Chinese population decreased by about 0.1 percent or 1.39 million to around 1.408 billion people. Declining population growth in China Due to strict birth control measures by the Chinese government as well as changing family and work situations of the Chinese people, population growth has subsided over the past decades. Although the gradual abolition of the one-child policy from 2014 on led to temporarily higher birth figures, growth rates further decreased in recent years. As of 2024, leading countries in population growth could almost exclusively be found on the African continent and the Arabian Peninsula. Nevertheless, as of mid 2024, Asia ranked first by a wide margin among the continents in terms of absolute population. Future development of Chinese population The Chinese population reached a maximum of 1,412.6 million people in 2021 but decreased by 850,000 in 2022 and another 2.08 million in 2023. Until 2022, China had still ranked the world’s most populous country, but it was overtaken by India in 2023. Apart from the population decrease, a clear growth trend in Chinese cities is visible. By 2024, around 67 percent of Chinese people lived in urban areas, compared to merely 36 percent in 2000.

Baby Diaper Machine Line Market Outlook

The global baby diaper machine line market size was valued at USD 1.5 billion in 2023 and is projected to reach USD 2.6 billion by 2032, growing at a CAGR of 6.2% during the forecast period. This growth can be attributed to a combination of factors including increasing birth rates in developing countries, rising disposable income, and advancements in diaper technology that demand efficient manufacturing processes.

One of the primary growth factors for the baby diaper machine line market is the increasing birth rates in emerging economies such as India, China, and various African nations. These regions are witnessing a rise in population driven by higher fertility rates and decreasing infant mortality rates. As the population grows, the demand for baby diapers also increases, thereby necessitating the need for efficient and high-capacity diaper manufacturing machines. Additionally, the urbanization trend in these regions is contributing to higher disposable incomes, making premium baby care products more accessible to a larger consumer base.

Another significant growth factor is the advancements in diaper technology. Modern-day diapers are designed to offer better absorption, improved fit, and increased comfort. This has led to the development of more sophisticated manufacturing processes, which require state-of-the-art machinery. Innovations such as biodegradable diapers and hypoallergenic materials are also driving the demand for advanced diaper machine lines that can produce these specialized products efficiently. Consequently, manufacturers are increasingly investing in machine upgrades and new installations to keep pace with technological advancements.

The growing awareness about hygiene and infant care is another key driver for market growth. Parents are becoming more conscious about the health and hygiene of their babies, leading to higher spending on baby care products, including diapers. The increasing availability of these products in both online and offline retail channels is making them more accessible to a broader audience. Moreover, government initiatives promoting infant health and hygiene also play a crucial role in boosting the market for baby diaper machines.

Regionally, North America and Europe have traditionally been strong markets for baby diaper machine lines due to the high demand for premium baby care products and advanced manufacturing capabilities. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. This can be attributed to the rapidly growing population, increasing disposable incomes, and the presence of numerous diaper manufacturing plants in countries like China and India. The Middle East & Africa and Latin America are also emerging as potential markets, driven by improving economic conditions and increasing consumer awareness.

Machine Type Analysis

The baby diaper machine line market can be segmented based on machine type into semi-automatic and fully automatic machines. Semi-automatic machines offer a balance between manual intervention and automation, providing flexibility and cost-effectiveness for small to medium-sized manufacturers. These machines are particularly popular in emerging markets where labor costs are relatively low and initial capital investment needs to be minimized. Semi-automatic machines allow manufacturers to scale up production gradually, making them an attractive option for start-ups and small enterprises.

Fully automatic machines, on the other hand, are designed for high-speed, high-volume production. These machines are equipped with advanced features such as real-time monitoring, quality control systems, and automated material handling, which significantly reduce the need for manual intervention. Fully automatic machines are ideal for large-scale manufacturers who need to meet high demand efficiently. The higher initial investment in these machines is often offset by the savings in labor costs and the increased production capacity they offer. As a result, fully automatic machines are gaining traction in developed markets where labor costs are high and production efficiency is paramount.

In terms of market growth, fully automatic machines are expected to witness a higher CAGR compared to semi-automatic machines. This growth is driven by the increasing demand for high-quality diapers and the need for manufacturers to stay competitive by adopting advanced manufacturing technologies. The integration of Industry 4.0 technologies, such as IoT and machine learning, into fully

According to a survey on the sex life in China released in 2019, majority of the young Chinese adults took different types of contraception when having sex. In that survey, around two-thirds of the respondents said they used condoms as a contraception, whereas 14 percent of the respondents relied on birth control pills.

Hospital Bassinet On Casters Market Outlook

The global market size for hospital bassinets on casters was valued at approximately USD 875 million in 2023 and is projected to reach around USD 1.25 billion by 2032, expanding at a compound annual growth rate (CAGR) of 4.1% during the forecast period. The market's growth is primarily driven by increasing birth rates, advancements in healthcare infrastructure, and heightened awareness about infant safety and care.

One of the major growth factors driving the hospital bassinet on casters market is the rising birth rates globally. As more families welcome new members, healthcare facilities must ensure that they are equipped with the necessary medical equipment to provide adequate care for neonates. The increasing investments in healthcare infrastructure, particularly in emerging economies, have led to the establishment and expansion of hospitals, clinics, and maternity centers, which in turn has boosted the demand for hospital bassinets equipped with casters for easy mobility.

Another significant factor fueling market growth is the technological advancements in medical devices. Modern hospital bassinets come equipped with features such as adjustable heights, storage compartments, and enhanced safety mechanisms, which improve the overall caregiving experience. These innovations cater not only to the convenience of healthcare professionals but also to the comfort and safety of the newborns. Furthermore, the trend of adopting smart healthcare solutions has led to the integration of digital monitoring systems within bassinets, providing real-time data on the infant's health metrics.

Additionally, there is an increasing awareness about the importance of specialized care for newborns. Parents and healthcare providers are becoming more conscious about the quality of care provided to infants. This awareness has led to a surge in demand for specialized bassinets that offer additional features like temperature control, anti-bacterial surfaces, and ergonomic designs. The emphasis on infection control and hygiene in healthcare settings has also contributed to the preference for advanced bassinet models.

Regionally, North America holds a significant share of the market, driven by well-established healthcare infrastructure and high healthcare expenditure. Europe follows closely, with countries like Germany, France, and the UK investing heavily in neonatal care. The Asia Pacific region is expected to witness the highest growth rate due to increasing investments in healthcare, rising birth rates, and improving economic conditions in countries such as China and India. The Middle East & Africa and Latin America are also expected to witness substantial growth, albeit at a slower pace compared to other regions, due to ongoing healthcare infrastructure developments and government initiatives to improve maternal and child healthcare services.

Product Type Analysis

The hospital bassinet on casters market can be segmented by product type into standard bassinets, convertible bassinets, and specialty bassinets. Standard bassinets are the most commonly used type and have been a staple in neonatal care for decades. These bassinets are typically simple in design and focus on providing a safe and comfortable space for newborns. They are widely adopted in hospitals and clinics due to their cost-effectiveness and ease of use. However, their limited features compared to more advanced models may restrict their growth potential in the coming years.

Convertible bassinets have gained popularity in recent years due to their versatile design. These bassinets can be adjusted or transformed to serve different purposes, such as converting into a crib or a changing station. The ability to modify the bassinet to suit various needs makes it an attractive option for healthcare providers looking to optimize space and resources. The growing preference for multifunctional medical equipment is expected to drive the demand for convertible bassinets, particularly in settings where space is a constraint.

Specialty bassinets cater to specific medical requirements and are equipped with advanced features such as temperature control, anti-bacterial surfaces, and integrated monitoring systems. These bassinets are designed to provide specialized care for premature or critically ill newborns. The increasing prevalence of preterm births and the rising focus on neonatal intensive care units (NICUs) have contributed to the demand for specialty bassinets. These advanced models, though more expensive, are essential in providing the

The global market for Warmers for Maternal Infant Care is experiencing robust growth, driven by increasing preterm births, rising awareness of neonatal care, and advancements in medical technology. The market, estimated at $1.5 billion in 2025, is projected to witness a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching approximately $2.7 billion by 2033. This expansion is fueled by several key factors. Firstly, the rising prevalence of premature births necessitates sophisticated temperature regulation for vulnerable infants. Secondly, the growing adoption of advanced features like servo-controlled temperature regulation and improved safety mechanisms in warmers are driving market demand. Finally, increasing healthcare expenditure in developing economies and the expansion of healthcare infrastructure are contributing to market growth. The hospital segment holds the largest market share due to the concentration of neonatal intensive care units (NICUs) within these facilities. However, the clinic segment is also expected to witness significant growth owing to increased outpatient care services for newborns. Servo-mode warmers are the dominant type, due to their precise temperature control and enhanced safety features, while manual-mode warmers cater to budget-conscious healthcare providers in certain regions. Leading players such as GE Healthcare and Parker Healthcare are focusing on product innovation, strategic partnerships, and geographic expansion to maintain their market share. Competitive intensity is expected to rise as new entrants from emerging economies enter the market. Regional analysis reveals that North America and Europe currently dominate the market, driven by high healthcare expenditure and advanced medical infrastructure. However, Asia Pacific is poised for significant growth, fueled by rising disposable incomes, improved healthcare access, and increasing birth rates in developing countries like India and China. This regional disparity provides considerable opportunity for market expansion and strategic investments by manufacturers. While regulations concerning medical device safety and market access could pose challenges, the overall market outlook remains optimistic, driven by the fundamental need for efficient and reliable temperature regulation for vulnerable newborns. Restraints to market growth include high initial investment costs for advanced warmers, potential limitations in healthcare infrastructure in developing nations, and varying regulatory landscapes across different regions.

As of 2023, the bulk of the Chinese population was aged between 25 and 59 years, amounting to around half of the population. A breakdown of the population by broad age groups reveals that around 61.3 percent of the total population was in working age between 16 and 59 years in 2023. Age cohorts below 25 years were considerably smaller, although there was a slight growth trend in recent years. Population development in China Population development in China over the past decades has been strongly influenced by political and economic factors. After a time of high fertility rates during the Maoist regime, China introduced birth-control measures in the 1970s, including the so-called one-child policy. The fertility rate dropped accordingly from around six children per woman in the 1960s to below two at the end of the 20th century. At the same time, life expectancy increased consistently. In the face of a rapidly aging society, the government gradually lifted the one-child policy after 2012, finally arriving at a three-child policy in 2021. However, like in most other developed countries nowadays, people in China are reluctant to have more than one or two children due to high costs of living and education, as well as changed social norms and private values. China’s top-heavy age pyramid The above-mentioned developments are clearly reflected in the Chinese age pyramid. The age cohorts between 30 and 39 years are the last two larger age cohorts. The cohorts between 15 and 24, which now enter childbearing age, are decisively smaller, which will have a negative effect on the number of births in the coming decade. When looking at a gender distribution of the population pyramid, a considerable gender gap among the younger age cohorts becomes visible, leaving even less room for growth in birth figures.

China life expectancy for 2025 is 77.81, a 0.22% increase from 2024.

<ul style='margin-top:20px;'>

<li>China life expectancy for 2024 was <strong>77.64</strong>, a <strong>0.22% increase</strong> from 2023.</li>
<li>China life expectancy for 2023 was <strong>77.47</strong>, a <strong>0.22% increase</strong> from 2022.</li>
<li>China life expectancy for 2022 was <strong>77.30</strong>, a <strong>0.22% increase</strong> from 2021.</li>
</ul>Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.

Snapshot img

Fertility Supplements Market Size 2024-2028

The fertility supplements market size is forecast to increase by USD 761.7 million at a CAGR of 7.08% between 2023 and 2028.

The market is experiencing significant growth, driven by the increasing number of individuals turning to supplements to address fertility issues. This trend is particularly prominent In the US and other developed markets, where the availability of e-commerce has made these supplements more accessible. However, the market is not without challenges. One major concern is the potential risks associated with fertility supplements, particularly those containing unregulated ingredients. This has led to increased scrutiny from regulatory bodies and calls for greater transparency and standardization in the industry. Despite these challenges, opportunities abound for companies that can navigate this complex landscape. By focusing on research and development of safe and effective supplements, and implementing strong quality control measures, companies can differentiate themselves and capture market share. Additionally, partnerships with healthcare providers and insurers can help expand reach and drive adoption, making this an exciting space for innovation and growth.

What will be the Size of the Fertility Supplements Market during the forecast period?

Request Free Sample

The market has experienced significant growth in recent years, driven by various factors. Rising healthcare costs and changing lifestyles have led individuals to seek affordable alternatives to conventional fertility treatments. Medical advancements have expanded the knowledge of infertility causes, such as smoking, alcohol consumption, poor diet, mental stress, hormonal imbalances, age, weight gain, and other factors. These issues have become increasingly prevalent in today's society, contributing to the market's expansion. Alpha-amylase, selenium, zinc, and other essential vitamins and minerals are commonly found in fertility supplements, addressing various infertility concerns. The market encompasses both synthetic and natural ingredients, catering to diverse consumer preferences.
Regulations and product safety concerns have emerged as critical factors, shaping the market's direction. The obese population, smoking rates, alcohol use rates, and stress levels continue to influence the market's growth trajectory. Acquisitions and partnerships have also played a role In the market's consolidation, as companies seek to expand their offerings and reach larger audiences.

How is this Fertility Supplements Industry segmented?

The fertility supplements industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Women
  Men


Geography

  North America

    US


  Europe

    France
    Germany
    UK


  APAC

    China


  South America



  Middle East and Africa

By End-user Insights

The women segment is estimated to witness significant growth during the forecast period. Fertility supplements have gained significant attention In the healthcare market due to the increasing prevalence of infertility among women. Infertility affects approximately 20-30% of women of reproductive age, with factors including polycystic ovary syndrome (PCOS), endometriosis, and pelvic inflammatory disease impacting the female reproductive system. Lifestyle factors, such as poor diet, smoking, and alcohol consumption, also contribute to infertility. Medical advancements and changing lifestyles have led to an increase In the use of fertility supplements, which contain natural ingredients like Myo-Inositol, Selenium, Zinc, Folic acid, Vitamin C, Vitamin B6, CoQ1, and Vitamin E. These supplements aim to address hormonal imbalances, improve sperm shape, motility, and counts, and enhance semen ejection.

Get a glance at the market report of share of various segments Request Free Sample

The women segment was valued at USD 861.60 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market size of various regions, Request Free Sample

The North American market is experiencing growth due to increasing infertility rates and heightened public awareness of overall health. Infertility is on the rise, influenced by factors such as alcohol consumption, smoking, obesity, and stress, which disrupt the endocrine system and lead to hormonal imbalances, according to the World Health Organization (WHO). The US Department of Health and Human Serv

Infant Resuscitation System Market Outlook

The global infant resuscitation system market size is projected to grow from USD 1.2 billion in 2023 to USD 2.3 billion by 2032, exhibiting a CAGR of 7.2% during the forecast period. This growth is driven primarily by the increasing birth rates in several countries, coupled with a growing awareness about neonatal care. The rising prevalence of preterm births and the subsequent need for effective resuscitation systems to ensure the survival and health of newborns, especially in developing regions, also serve as significant growth factors for this market.

A major growth factor for the infant resuscitation system market is the advancement in medical technologies. Innovations such as integrated monitoring systems that offer real-time data on the infant's vital signs have significantly enhanced the effectiveness of resuscitation efforts. These advancements not only improve survival rates but also reduce the long-term health complications associated with birth asphyxia. Additionally, the development of user-friendly and automated resuscitation systems is making these devices more accessible to a wider range of healthcare providers, thereby broadening the market scope.

Another crucial contributor to market growth is the increasing governmental and non-governmental initiatives aimed at reducing neonatal mortality rates. Organizations such as the World Health Organization (WHO) and UNICEF are actively working towards improving maternal and infant health outcomes globally. These initiatives often include the provision of essential medical equipment, including infant resuscitation systems, to lower-income countries where healthcare infrastructure may be lacking. Consequently, such initiatives are expected to fuel market growth over the forecast period.

The rising awareness and education among parents and healthcare providers about the critical importance of neonatal care also play a significant role in market expansion. Training programs and workshops designed to educate healthcare providers on the latest resuscitation techniques and technologies are becoming more common. This increasing focus on professional training ensures that healthcare providers are well-equipped to handle neonatal emergencies, thereby driving demand for advanced resuscitation systems. Additionally, parents are becoming more informed about the risks associated with childbirth complications, thereby increasing the demand for hospitals and clinics to be adequately equipped.

Regionally, North America and Europe are expected to dominate the infant resuscitation system market due to their well-established healthcare infrastructure and higher investment in medical technologies. However, the Asia Pacific region is projected to witness the highest growth rate, driven by a substantial increase in birth rates and improving healthcare facilities. Countries like China and India are experiencing significant investments in their healthcare sectors, which is expected to boost the adoption of advanced neonatal care equipment, including resuscitation systems. Additionally, governmental policies encouraging the improvement of maternal and child health are further propelling market growth in this region.

Product Type Analysis

The infant resuscitation system market is segmented by product type into manual resuscitators and automated resuscitators. Manual resuscitators are widely used due to their simplicity and cost-effectiveness. These devices are essential in emergency situations where automated systems might not be available, especially in resource-limited settings. Manual resuscitators provide healthcare providers with the flexibility to control the ventilation process, which can be crucial in specific medical scenarios. However, their effectiveness is heavily dependent on the skill level of the healthcare provider, which can be a limiting factor in some cases.

Automated resuscitators, on the other hand, are gaining popularity due to their advanced features and ease of use. These systems are designed to deliver consistent and controlled ventilation, reducing the margin for human error. Automated resuscitators often come with integrated monitoring capabilities that provide real-time data on the infant's vital signs, enabling more precise and effective resuscitation efforts. The higher initial cost of automated systems is offset by their long-term benefits, including reduced training requirements and improved patient outcomes. Consequently, the demand for automated resuscitators is expected to rise significantly during the forecast period.

Snapshot img

Assisted Reproductive Technology Market Size 2024-2028

The assisted reproductive technology (ART) market size is forecast to increase by USD 6.3 billion at a CAGR of 4.36% between 2023 and 2028.

The market is experiencing significant growth due to the increasing rate of infertility cases, fertility supplements and the rising number of single-parent families. Infertility affects approximately 15% of couples worldwide, and this number is projected to increase. Additionally, the trend of single parenthood is on the rise, with over 30 million single parents in the United States alone. These demographic shifts are driving the demand for ART solutions, as they offer a viable option for individuals and couples seeking to start a family. However, the ART market also faces challenges. Side effects of infertility treatments, such as multiple pregnancies, ovarian hyperstimulation syndrome, and emotional stress, can deter potential patients.
These risks, coupled with the high cost of treatments, can limit market penetration. It is crucial for market players to address these challenges by investing in research and development of safer and more affordable ART solutions. By focusing on improving patient outcomes and reducing the financial burden, companies can capitalize on the growing demand for ART services and maintain a competitive edge in this dynamic market.

What will be the Size of the Assisted Reproductive Technology (ART) Market during the forecast period?

Request Free Sample

The market dynamics continue to evolve, driven by advancements in reproductive medicine and the expanding application across various sectors. Infertility treatment, a significant market segment, integrates ovulation induction, third-party reproduction, and hormonal therapy. Fertility preservation, another evolving area, encompasses donor eggs, egg retrieval, and embryo culture, catering to individuals undergoing medical treatments or choosing to delay parenthood. Stress and infertility are increasingly recognized as interconnected, leading to a growing emphasis on lifestyle modifications. Reproductive health concerns, such as chromosomal abnormalities and single gene disorders, are addressed through advanced diagnostic tools and reproductive surgery. Male infertility, a prevalent issue, is addressed through assisted hatching and sperm analysis.
Fertility clinics, reproductive centers, and fertility specialists leverage ART technologies to provide comprehensive services, including infertility diagnosis, fertility medications, and embryo transfer. Fertility apps and tracking tools facilitate patient engagement and support, while reproductive endocrinology continues to unravel the complexities of human reproduction. Environmental toxins and age-related infertility are emerging challenges, prompting ongoing research in stem cell research and reproductive medicine. The market landscape remains dynamic, with ongoing advancements in ART technologies and applications, ensuring a continuous unfolding of market activities.

How is this Assisted Reproductive Technology (ART) Industry segmented?

The assisted reproductive technology (ART) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-User

  Fertility clinics
  Hospitals
  Surgical centers
  Research institutes/labs
  Cryobanks


Type

  IVF
  ARTificial insemination
  GIFT (Gamete Intrafallopian Transfer)
  ZIFT (Zygote Intrafallopian Transfer)
  Surrogacy
  Donor egg/sperm ART


Product

  Instrument
  Accessory and Disposable
  Reagents and Media
  Software


Geography

  North America

    US


  Europe

    France
    Germany
    Netherlands
    UK


  Middle East and Africa

    UAE


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By End-User Insights

The fertility clinics segment is estimated to witness significant growth during the forecast period.

Request Free Sample

Fertility clinics lead the assisted reproductive technology (ART) market, driven by a global surge in fertility centers addressing the rising demand from infertility patients. The success rates of these clinics measured by pregnancies or live births per treatment annually-are pivotal, boosting their reputation as top fertility treatment destinations in both domestic and international markets. Enhanced infrastructure in fertility clinics supports medical tourism for infertility treatment, though demand fluctuates due to economic factors, exchange rates, and external factors during 2025-2029. Organizations like ESHRE, ASRM, and ICMART work to standardize fertility tourism, minimizing exploitation and risks. However, stringent regulations pose challenges, with non-compliance leading to fine

In 2023, about 982.9 million people in China were estimated by the UN to be at a working age between 15 and 64 years. After a steep increase in the second half of the 20th century, the size of the working-age population reached a turning point in 2015 and figures started to decrease thereafter. Changes in the working-age population China's demographic development is characterized by a rapid change from a high fertility rate to a low one. This has caused the development of an arc shaped graph of the working age population: quickly increasing numbers before 2010, a gradual turn with a minor second peak until around 2027, and a steep decline thereafter. The expected second maximum of the graph results from the abolishment of birth control measures after 2010, which proved less successful in increasing birth figures than expected. The same turn can be seen in the number of people eligible for work, with an accelerated downturn in the years of the coronavirus pandemic, where many people left the labor force. It is very likely that the size of the labor force will rebound slightly in the upcoming years, but the extent of the rebound, which parallels the second maximum of the working age population, might be limited. China's labor market China's labor market was once defined by its abundant and cheap labor force, but competition for talent has been getting increasingly tense in recent years. This development is very likely to further intensify and extend itself into the less skilled ranks of the labor market. As the number of people who fall within the retirement age group is increasing and adding to the burden on the economy, steps to keep labor participation high are necessary. Raising the retirement age and providing incentives to stay in the labor force, are measures being implemented by Chinese government. Strategies to increase labor productivity would be ideal to mitigate the pressure on the Chinese economy, however, realizing such strategies is challenging.

This graph shows the average size of households in China from 1990 to 2023. That year, statistically about 2.8 people were living in an average Chinese household. Average household size in China A household is commonly defined as one person living alone or a group of people living together and sharing certain living accommodations. The average number of people living in one household in China dropped from 3.96 in 1990 to 2.87 in 2011. Since 2010, the figure was relatively stable and ranged between 2.87 and 3.17 people per household. The average Chinese household still counts as rather large in comparison to other industrial countries. In 2023, an average American household consisted of only 2.51 people. Comparable figures have already been reached in the bigger cities and coastal areas of China, but in the rural provinces the household size is still much larger. According to the National Bureau of Statistics of China, the household size in China was diametrically correlated to its income. Birth rates and household sizes The receding size of Chinese households may be linked to the controversial one-child policy introduced in 1979. The main aim of the policy was to control population growth. While the fertility rate in China had been very high until the 1970s, it fell considerably in the following decades and resided at only 1.7 children per woman in 2018, nearly the same as in the United States or in the United Kingdom. A partial ease in the one-child policy was introduced in 2013, due to which couples where at least one parent was an only child were allowed to have a second child. In October 2015, the law was changed into a two-child policy becoming effective in January 2016.